Clinical Trials Directory

Trials / Completed

CompletedNCT05933291

Single-cell Landscape of BALF in Patients With Severe ARDS and CARDS

Single-cell Landscape of BALF in Patients With Severe ARDS and CARDS: an Analysis of the Effectiveness of Steroid Therapy and a Comparison Between COVID-19 ARDS and ARDS From Other Etiologies

Status
Completed
Phase
Study type
Observational
Enrollment
8 (actual)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

The goal of this observational study is to learn about the effect of steroid therapy in patients with COVID-19 ARDS. The main questions it aims to answer are: * Differences between patients with COVID-19 ARDS before and after steroid treatment in BALF single cell landscape, as well as patients with different prognosis. * Differences between COVID-19 and non COVID-19 ARDS patients in BALF single cell landscape. Participants will Choose whether to use or not to utilize steroid treatment based on conditions.

Detailed description

Collect BALF from COVID-19 and non-COVID-19 ARDS patients both before and during remission, then perform single-cell sequencing.

Conditions

Interventions

TypeNameDescription
DRUGsteroidModerate- or high-dose steroids

Timeline

Start date
2022-09-24
Primary completion
2023-02-09
Completion
2023-03-15
First posted
2023-07-06
Last updated
2023-07-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05933291. Inclusion in this directory is not an endorsement.